Experiments confirm that RPS3 is essential for normal expression of specific NF-kappaB target genes, including key physiological events that require p65. More
New methods for treating, minimizing and/or preventing inflammatory injury mediated by the activity of interleukin 2 (IL-2) on non-T cells, such as epithelial cells, expressing IL-2 receptors (IL-2R) More
This invention concerns a new approach to the treatment of rheumatoid arthritis (RA) by "tolerogenic vaccination" with small interfering RNA (siRNA) technology. More
Lead Inventor: Gregg G. Gundersen, Ph.D. Problem or Unmet Need: As the incidence of cancer continues to rise, additional therapeutic technologies are needed more than ever. Current adjuvant therapies inject hormones, antibodies, or other peptides into... More
Displaying 11..17 of 17 -
per page
Previous page
Order by
All rights reserved. Terms and Conditions | Contact us
